25 of the Best Oncologists Near Me in Farmingdale, NY

Louis Kavoussi, MD, MBA, Director of teleintervention at Northwell. He is a world-renowned urologic surgeon who brings more than 30 years of specialized expertise in minimally invasive urological surgery. His area of focus includes treating a wide range of urologic diseases, including kidney obstructions, renal stones and urologic cancer. At the forefront of innovation, Dr. Kavoussi pioneered several new surgical techniques, including the first minimally invasive approaches to kidney surgery for kidney cancer and kidney donation. He was also part of the team that performed the first laparoscopic prostate removal for cancer. In 1999, Dr. Kavoussi received a Smithsonian Computerworld Permanent Collection award for his work in developing telerounding, the starting point of telehealth medicine-to facilitate physician communication with hospitalized patients. Before joining Northwell in 2005 as chair of urology, Dr. Kavoussi completed his medical degree at the State University of New York at Buffalo. He obtained his urologic training at Washington University of St. Louis and, directly following residency, was named chief of urology at the Jewish Hospital of St. Louis. In 1991, he was appointed assistant professor at Harvard School of Medicine and director of endourology at the Brigham and Women's Hospital. In 1993, he joined the faculty of Johns Hopkins University School of Medicine, where he was vice chairman of urology and named a Patrick C. Walsh Distinguished Professor. Dr. Kavoussi values a team approach to care, and often collaborates with other specialists to create personalized and comprehensive treatment plans. His patients appreciate his easygoing personality and thoughtfulness. As the Waldbaum-Gardner Distinguished Professor of Urology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Dr. Kavoussi is passionate about training the next generation of surgeons. He has presented his work and given live surgical demonstrations at conferences around the world and has more than 500 academic publications. Dr. Kavoussi is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Reconstructive Urology Surgery. Dr. Kavoussi is board certified in American Board Of Urology.

Nagashree Seetharamu, MD, MBBS, is an Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology, Medical Oncology and Hospice/Palliative medicine, she specializes in cancers of the head and neck and thoracic malignancies (lung cancer, mesothelioma, thymic tumors). She maintains an active clinical practice at the Monter Cancer Center where she focuses on providing compassionate, personalized, evidence-based multidisciplinary care. Dr. Seetharamu has established her reputation at the national level through her active involvement, and leadership within influential oncology organizations that steer the direction of clinical cancer care and research across the United States, and globally. She is a full member of both the Cancer Prevention Committee and Respiratory Committee of Alliance for Clinical Trials in Oncology. This is a national, NCI-sponsored, cooperative group that develops, fund and conducts clinical trials at many academic and community oncology centers across the country. In her position on these committees, she collaborates with clinical research experts across the country to establish standards-of-care, oversees the conduct of existing clinical trials, develops innovative and impactful hypotheses, and formulate future clinical trials. Dr. Seetharamu is the institutional principal investigator on over 10 clinical trials, has co-authored over 50 publications and book chapters and is a sought after speaker at various regional, national and international events related to Head and Neck and Thoracic cancer. Dr. Seetharamu is also Associate Program Director of the Medical Oncology and Hematology Fellowship Program for the Northwell Health Cancer Institute. In this role, she provides hands-on involvement in the recruitment, education and mentorship of future generations of physicians. Dr. Seetharamu trained in internal medicine at Long Island Jewish Medical Center and in hematology/oncology at New York University Medical Center. Dr. Seetharamu is highly rated in 28 conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer. Dr. Seetharamu is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hospice & Palliative Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

I am a board certified medical oncologist treating all solid tumor malignancies,with special expertise in gastrointestinal malignancies, gynecological malignancies and head and neck cancer. I am the Director of GI Malignancies for the Eastern Region at Northwell Health Cancer Institute, and Chief of Hematology Oncology at Huntington Hospital. I collaborate with a multidisciplinary team of physicians, surgeons, radiation oncologists, pathologists, and radiologists to bring the best possible care to patients who wish to be treated close to home on Long Island. I am also an attending physician of the Don Monti Division of Medical Oncology and Hematology at North Shore University Hospital, Long Island Jewish Medical Center and Southside Hospital. Prior to joining Northwell Health, I was an attending physician at Memorial Sloan Kettering Cancer Center. I completed my Internal Medicine residency training at Maimonides Medical Center and my fellowship in Hematology and Oncology at the University of Vermont. In addition to my work as a clinician, I have a strong interest in clinical research. I immensely enjoy teaching and have mentored many young physicians during their training. I am proud to be part of a dedicated multidisciplinary team, providing state- of-the-art comprehensive care to all of our patients on Long Island. Dr. Siebel is highly rated in 27 conditions, according to our data. Her clinical expertise encompasses Familial Colorectal Cancer, Colorectal Cancer, Merkel Cell Carcinoma, and Lynch Syndrome. Dr. Siebel is board certified in American Board Of Internal Medicine/Medical Oncology.

Bruce Kappel is a Hematologist and an Oncologist practicing medicine in Woodbury, New York. He has been practicing medicine for over 44 years. Dr. Kappel is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Hemangioma Thrombocytopenia Syndrome, Adult Immune Thrombocytopenia, and Immune Thrombocytopenic Purpura (ITP). Dr. Kappel is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Douglas Gladstone is a Transplant Surgeon practicing medicine in Lake Success, New York. Dr. Gladstone is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Hairy Cell Leukemia (HCL), Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Hodgkin Lymphoma, and Bone Marrow Aspiration.

Nancy Sun is a Hematologist and an Oncologist practicing medicine in Woodbury, New York. Dr. Sun is highly rated in 22 conditions, according to our data. Her clinical expertise encompasses Hemangioma Thrombocytopenia Syndrome, Paris-Trousseau Thrombocytopenia, RUNX1 Familial Platelet Disorder, and Immune Thrombocytopenic Purpura (ITP). Dr. Sun is board certified in American Board Of Internal Medicine/Hematology and American Board Of Internal Medicine/Medical Oncology.

Kevin Holcomb is an Oncologist practicing medicine in New Hyde Park, New York. Dr. Holcomb is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Oophorectomy, and Salpingo-Oophorectomy. Dr. Holcomb is board certified in American Board Of Obstetrics & Gynecology and American Board Of Obstetrics & Gynecology-Gynecologic Oncology.

Lisa Santos is an Oncologist practicing medicine in Huntington, New York. Dr. Santos is highly rated in 17 conditions, according to our data. Her clinical expertise encompasses Endometrial Stromal Sarcoma, Endometrial Cancer, Angiomyoma, Hernia Surgery, and Hysterectomy. Dr. Santos is board certified in American Board Of Obstetrics & Gynecology and American Board Of Obstetrics & Gynecology-Gynecologic Oncology.

Veena John, MD, is the System Head for GYN/Medical Oncology for the Northwell Health Cancer Institute and an Assistant Professor of Medicine in the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology and Medical Oncology, she maintains an active practice caring for patients with gynecologic cancers where she focuses on providing compassionate, personalized, evidence-based multi-disciplinary care. In conjunction with physicians in Surgical Oncology, she pioneered a multi-disciplinary team approach for gynecologic oncology patients at the R.J. Zuckerberg Cancer Center where her practice is based. Dr. John is a highly experienced principal investigator for industry sponsored Phase I, II and III clinical trials in gynecologic oncology. She is the site principal investigator for the NRG cooperative group for the Northwell Health Cancer Institute and co-chair of the protocol review monitoring committee. Dr. John earned her medical degree from Christian Medical College in India, where she also completed her internal medicine internship. She completed her internal medicine residency at Flushing Medical Center and fellowship in hematology and medical oncology at North Shore University Hospital. She is an active member of the Society for Gynecologic Oncology, Society for Immunotherapy in Cancer, American Society of Clinical Oncology and American Society of Hematology as well as a member of the Ovarian Cancer committee for the national Gynecologic Oncology Group. Dr. John is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Testicular Yolk Sac Tumor, and Malignant Mixed Mullerian Tumor. Dr. John is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Joan Tymon is an Oncologist practicing medicine in New Hyde Park, New York. Dr. Tymon is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Ovarian Carcinosarcoma, Ovarian Cancer, Malignant Mixed Mullerian Tumor, Hysterectomy, and Oophorectomy. Dr. Tymon is board certified in American Board Of Obstetrics & Gynecology.

Richard Carvajal is an Oncologist practicing medicine in Lake Success, New York. Dr. Carvajal is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Metastatic Uveal Melanoma, Uveal Melanoma, Melanoma of the Eye, Melanoma, and Tissue Biopsy. Dr. Carvajal is board certified in American Board Of Internal Medicine/Medical Oncology.

Magdalena Pomykol is a Hematologist and an Oncologist practicing medicine in Greenlawn, New York. Dr. Pomykol is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer, Multiple Myeloma, Anemia, and Thrombocytopenia.

The Chronic Lymphocytic Leukemia (CLL) Research and Treatment Program has become a landmark for CLL patients worldwide. Dr. Kanti Rai has been involved in diagnosing and treating CLL for almost 40 years and the staging system that bears his name came out of his early breakthrough research. His particular areas of interest are: natural history of CLL, improving prognostic features of this disease and developing newer strategies of therapy which are hypothesis-driven. Dr. Rai is an active member of the International Workshop on CLL (iwCLL) and Dr. Keating s Global CLL Foundation. He is an active member of the American Society of Clinical Oncology (ASCO), American Association for Cancer Research (AACR) and the American Society of Hematology (ASH). In 2006, Dr. Rai served as the President of ASH. He was the recipient of ASCO s David Karnofsky Memorial Award in 2012. In 2013, Dr. Rai was honored with the iwCLL David Galton award. In 2014 he was presented with ASH s Wallace H. Coulter Lifetime Achievement Award. Dr. Rai is the Joel Finkelstein Cancer Foundation Professor of Medicine, and Professor of Molecular Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell School of Medicine and Professor of Medicine at the Feinstein Institute for Medical Research, Manhasset, NY. Dr. Rai is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Leukemia, and Richter Syndrome. Dr. Rai is board certified in American Board Of Pediatrics.

Jennifer Lue is a Hematologist and an Oncologist practicing medicine in Commack, New York. Dr. Lue is highly rated in 19 conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Lue is currently accepting new patients.

Raphael Steiner is a Hematologist and an Oncologist practicing medicine in Uniondale, New York. Dr. Steiner is highly rated in 16 conditions, according to our data. His clinical expertise encompasses B-Cell Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Tissue Biopsy, and Bone Marrow Aspiration. Dr. Steiner is currently accepting new patients.

Yair Keilson is an Oncologist practicing medicine in Massapequa, New York. Dr. Keilson is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Childhood Iron Deficiency Anemia, Familial Colorectal Cancer, Small Cell Lung Cancer (SCLC), and Paget Disease of the Breast.

Robert Stuver is a Hematologist and an Oncologist practicing medicine in Commack, New York. Dr. Stuver is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Peripheral T-Cell Lymphoma, T-Cell Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, and Bone Marrow Transplant. Dr. Stuver is currently accepting new patients.

Natalya Krichmar is a Hematologist practicing medicine in Massapequa, New York. Dr. Krichmar is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Angiosarcoma, Iron Deficiency Anemia, and Bone Marrow Aspiration.

Maximilian Merz is a Hematologist and an Oncologist practicing medicine in Commack, New York. Dr. Merz is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Acute Myeloid Leukemia (AML), and Bone Marrow Transplant. Dr. Merz is currently accepting new patients.

David Tuveson is an Oncologist practicing medicine in Cold Spring Harbor, New York. Dr. Tuveson is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Trophoblastic Tumor Placental Site, Hepato-Pancreato-Biliary Surgery, and Pancreatectomy.

Steven L. Allen, MD, FACP, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. An expert in benign and malignant hematology, he is the System Head for Benign Hematology for the Northwell Health Cancer Institute. As an attending physician at the Monter Cancer Center, Dr. Allen focuses on providing compassionate, personalized, evidence-based multi-disciplinary care. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Allen has been the principal investigator for numerous drug trials and has collaborated with several basic science labs, resulting in over 150 publications. Among his many professional affiliations, he is most active with the American Society of Hematology, having served in numerous leadership positions and committees. In addition, he is a dedicated member of the American Society of Clinical Oncology, Empire State Hematology and Oncology Society, and the American College of Physicians. Dr. Allen earned his medical degree from the Johns Hopkins School of Medicine. He trained in internal medicine and hematology/oncology at New York Hospital-Weill Cornell Medical Center. Dr. Allen is highly rated in 43 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Follicular Lymphoma, and Bone Marrow Aspiration. Dr. Allen is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Dr. Simon J Hall MD is a board certified urologist with Fellowship training in Urologic Oncology. His clinical interests include the diagnosis and treatment of Prostate, Bladder and Kidney cancers. He is especially interested in Active Surveillance of men with prostate cancer and men and women with incidentally found small renal masses and the creation of continent urinary reconstructions for patients who need to undergo cystectomy for Bladder cancer. Furthermore, Dr. Hall has a keen interest in treating patients with recurrent prostate cancer following definitive therapy. He believes that objective & balanced communication with the patient and family is the key to decision making and individualized care. Over the years Dr. Hall has been named as Best Doctor, both nationally and regionally, by organizations such as Castle Connolly, SuperDoctors and New York Magazine. Dr. Hall s research has focused of new therapies for prostate and bladder cancer; he has participated in numerous clinical trials, some of which generated data resulting in FDA approval of Sipleucel-T (Provenge) and enzulutamide (Xtandi). He oversees a laboratory investigating novel approaches to negating the Androgen Receptor, an important key driver of castration resistant prostate cancer. Decision making and improved methods of clinical care for patients with bladder and prostate cancer are important aspects of his research interests in collaboration with Dr. Michael Diefenbach, a behavioral scientist in the Departments of Urology & Medicine at NS-LIJ. He has authored or co-authored nearly 70 peer reviewed articles in Journals such as Journal of Urology, Urology, British Journal of Urology, Clinical Cancer Research and Science. Dr. Hall received his MD from the College of Physicians & Surgeons of Columbia University. He then completed two years of Surgery training at the Mount Sinai Medical Center followed by a four year residency in Urology at Boston University School of Medicine. This was followed by a 2 year fellowship in Urologic Oncology in the Scott Department of Urology at Baylor College of Medicine. Prior to joining the Smith Institute for Urology, he served on the faculty of Icahn School of Medicine at Mount Sinai for 18 years, holding various positions including Kyung Hyun Kim MD Chair of Urology and the Director of the Deane Prostate Health & Research Center. Dr. Hall is highly rated in 32 conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Prostate Cancer, Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery. Dr. Hall is board certified in American Board Of Urology.

Michael Buchholtz is a Hematologist and an Oncologist practicing medicine in Huntington, New York. Dr. Buchholtz is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Thrombocytopenia, Small Cell Lung Cancer (SCLC), and Anemia.

As Director of Quality and Patient Safety for Medical Oncology at the Monter Cancer Center, Dr. Tony Philip is committed to improving clinical outcomes. Board Certified in Hematology and Medical Oncology, Dr. Philip s clinical practice is solely dedicated to the treatment of patients with gastrointestinal cancers and sarcomas (cancers of the soft tissue and bone). He maintains an active medical practice focusing on compassionate, personalized, evidence-based multi-disciplinary care. He participates in research focused on improving the care of patients with these diseases. Currently an Assistant Professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Dr. Philip completed his Hematology/Oncology fellowship at North Shore-LIJ and his internal medicine residency at Long Island Jewish Medical Center. Dr. Philip earned his MD at University at Buffalo School of Medicine and Biomedical Sciences. He is an active member of the American Society of Clinical Oncology, Connective Tissue Oncology Society, and American College of Physicians. Dr. Philip completed the Northwell Physician Leadership Development Program and the American Society of Clinical Oncology Quality Program. Dr. Philip is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Undifferentiated Pleomorphic Sarcoma, Rhabdomyosarcoma Embryonal, Adult Soft Tissue Sarcoma, and Colorectal Cancer. Dr. Philip is board certified in American Board Of Internal Medicine/Hematology and American Board Of Internal Medicine/Medical Oncology.

"Andrew Menzin, MD, is an OB/GYN and oncology specialist at Northwell Health Physician Partners Gynecologic Oncology at New Hyde Park. He is also the chief of gynecologic oncology for Northwell facilities across central Long Island and Queens, and the vice chairman of academic affairs for the OB/GYN service line. Dr. Menzin has nearly three decades of experience in gynecologic oncology and academic medicine.""I come from a family of doctors,"" he says. ""Education, medicine and service to others was just part of how I grew up.""Dr. Menzin treats the full spectrum of gynecologic issues, from benign conditions to all malignancies of the female reproductive system. His extensive surgical expertise includes cancer surgery, robotic surgery and complex gynecologic surgery.He joined Northwell Health in 1995, after completing a fellowship in gynecologic oncology and a residency in obstetrics and gynecology at the Hospital of the University of Pennsylvania.""At Northwell, we're here to meet every patient's needs and deliver truly collaborative care,"" says Dr. Menzin, who works closely with specialists including pathologists, radiologists, medical oncologists, radiation oncologists, general surgeons, colorectal surgeons and urologists. He carefully explains this multifaceted care to each patient-even drawing his unique diagrams for extra clarity.Dr. Menzin is a professor of obstetrics and gynecology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. He is a member of the Society of Gynecologic Oncology, as well as a fellow of the American College of Surgeons and the American College of Obstetricians and Gynecologists. He's been named numerous times on the Castle Connolly Top Doctors list, and he's an avid supporter of the National Ovarian Cancer Coalition, which supports ovarian cancer survivors and funds research to find a cure.""I have had great mentors who've inspired me along the way,"" says Dr. Menzin. ""It's all about delivering care that's patient-centered. Looking after them the way I'd want to be cared for.""". Dr. Menzin is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, Hernia Surgery, and Hysterectomy. Dr. Menzin is board certified in American Board Of Obstetrics & Gynecology and American Board Of Obstetrics & Gynecology-Gynecologic Oncology.